Neurochemical basis for symptomatic treatment of Alzheimer's disease
10.1016/j.neuropharm.2010.02.010
Saved in:
| Main Authors: | , , |
|---|---|
| Other Authors: | |
| Format: | Review |
| Language: | English |
| Published: |
PERGAMON-ELSEVIER SCIENCE LTD
2021
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/188401 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| Language: | English |
| id |
sg-nus-scholar.10635-188401 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1884012023-09-13T21:42:28Z Neurochemical basis for symptomatic treatment of Alzheimer's disease Francis, Paul T Ramirez, Maria J Lai, Mitchell K DEPT OF PHARMACOLOGY Science & Technology Life Sciences & Biomedicine Neurosciences Pharmacology & Pharmacy Neurosciences & Neurology Alzheimer's disease Neurochemistry Cholinergic Serotonergic Glutamatergic GABAergic 5-HT6 RECEPTOR ANTAGONIST CHOLINE-ACETYLTRANSFERASE ACTIVITY METHYL-D-ASPARTATE MILD COGNITIVE IMPAIRMENT DOUBLE-BLIND SENILE-DEMENTIA BEHAVIORAL SYMPTOMS CEREBRAL-CORTEX MESSENGER-RNA ADRENERGIC-RECEPTORS 10.1016/j.neuropharm.2010.02.010 NEUROPHARMACOLOGY 59 4-May 221-229 UNITED KINGDOM 2021-04-06T03:38:22Z 2021-04-06T03:38:22Z 2010-09-01 2021-04-03T05:19:25Z Review Francis, Paul T, Ramirez, Maria J, Lai, Mitchell K (2010-09-01). Neurochemical basis for symptomatic treatment of Alzheimer's disease. NEUROPHARMACOLOGY 59 (4-May) : 221-229. ScholarBank@NUS Repository. https://doi.org/10.1016/j.neuropharm.2010.02.010 00283908 18737064 https://scholarbank.nus.edu.sg/handle/10635/188401 en PERGAMON-ELSEVIER SCIENCE LTD Elements |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| language |
English |
| topic |
Science & Technology Life Sciences & Biomedicine Neurosciences Pharmacology & Pharmacy Neurosciences & Neurology Alzheimer's disease Neurochemistry Cholinergic Serotonergic Glutamatergic GABAergic 5-HT6 RECEPTOR ANTAGONIST CHOLINE-ACETYLTRANSFERASE ACTIVITY METHYL-D-ASPARTATE MILD COGNITIVE IMPAIRMENT DOUBLE-BLIND SENILE-DEMENTIA BEHAVIORAL SYMPTOMS CEREBRAL-CORTEX MESSENGER-RNA ADRENERGIC-RECEPTORS |
| spellingShingle |
Science & Technology Life Sciences & Biomedicine Neurosciences Pharmacology & Pharmacy Neurosciences & Neurology Alzheimer's disease Neurochemistry Cholinergic Serotonergic Glutamatergic GABAergic 5-HT6 RECEPTOR ANTAGONIST CHOLINE-ACETYLTRANSFERASE ACTIVITY METHYL-D-ASPARTATE MILD COGNITIVE IMPAIRMENT DOUBLE-BLIND SENILE-DEMENTIA BEHAVIORAL SYMPTOMS CEREBRAL-CORTEX MESSENGER-RNA ADRENERGIC-RECEPTORS Francis, Paul T Ramirez, Maria J Lai, Mitchell K Neurochemical basis for symptomatic treatment of Alzheimer's disease |
| description |
10.1016/j.neuropharm.2010.02.010 |
| author2 |
DEPT OF PHARMACOLOGY |
| author_facet |
DEPT OF PHARMACOLOGY Francis, Paul T Ramirez, Maria J Lai, Mitchell K |
| format |
Review |
| author |
Francis, Paul T Ramirez, Maria J Lai, Mitchell K |
| author_sort |
Francis, Paul T |
| title |
Neurochemical basis for symptomatic treatment of Alzheimer's disease |
| title_short |
Neurochemical basis for symptomatic treatment of Alzheimer's disease |
| title_full |
Neurochemical basis for symptomatic treatment of Alzheimer's disease |
| title_fullStr |
Neurochemical basis for symptomatic treatment of Alzheimer's disease |
| title_full_unstemmed |
Neurochemical basis for symptomatic treatment of Alzheimer's disease |
| title_sort |
neurochemical basis for symptomatic treatment of alzheimer's disease |
| publisher |
PERGAMON-ELSEVIER SCIENCE LTD |
| publishDate |
2021 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/188401 |
| _version_ |
1779153283882942464 |